Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion

S. Anevlavis, I. Sotiriou, G. Kouliatsis, D. Bouros, M. Froudarakis (Alexandroupolis, Greece)

Source: Annual Congress 2009 - Trends in bronchoscopy
Session: Trends in bronchoscopy
Session type: E-Communication Session
Number: 2913
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Anevlavis, I. Sotiriou, G. Kouliatsis, D. Bouros, M. Froudarakis (Alexandroupolis, Greece). Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion. Eur Respir J 2009; 34: Suppl. 53, 2913

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy
Source: Annual Congress 2011 - From outside to inside: access to the pleura
Year: 2011

Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008


Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Karnofsky score, pH and degree of pleural involvement as prognostic factors for survival in patients with malignant pleural effusions
Source: Annual Congress 2012 - Chest wall, thoracic trauma and complications in thoracic surgery
Year: 2012


CD8+ lymphocyte subpopulations in pleural fluid are associated with longer survival in patients with malignant pleural effusion (MPE) submitted to thoracoscopic talc pleurodesis
Source: Eur Respir J 2002; 20: Suppl. 38, 70s
Year: 2002

The role of surgery in cytologically positive pleural effusion in NSCLC
Source: Annual Congress 2003 - Lung cancer surgery: prognostic factors
Year: 2003


The role of diagnostic thoracoscopy in patients with lung cancer and pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 542s
Year: 2003

Predictors of successful pleurodesis for patients with malignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 493s
Year: 2004

Impact of sarcopenia in long-term symptoms in patients with malignant pleural effusion.
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021


Prognostic factors associated to survival in patients with malignant pleural effusion (MPE) undergoing talc poudrage pleurodesis (TPP)
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung?
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019




Systemic treatment of malignant pleural effusion
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma?
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003

Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


Medical thoracoscopy for diagnosis of pleural effusion in cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 528s
Year: 2004

Pleurodesis after intrapleural catheter insertion is an independent factor for overall survival in patients with malignant pleural effusions
Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours
Year: 2009



Diagnostic thoracoscopy in patients with lung cancer and pleural effusion
Source: Annual Congress 2007 - Pleural techniques and diagnosis of peripheral lung nodules
Year: 2007